Skip to main navigation
Skip to search
Skip to main content
Discovery - the University of Dundee Research Portal Home
Home
Profiles
Research units
Research Outputs
Projects
Datasets
Theses
Activity
Press/Media
Research Facilities
Prizes
Search by expertise, name or affiliation
Analysing the impact of gabapentinoid reclassification on prescribing rates in the UK
Natalia Dygas
(Lead / Corresponding author)
, Fiona Cowden
, Kirsty Licence
,
Huan Wang
,
Blair H. Smith
,
Lesley Colvin
,
Harry Hebert
Population Health and Genomics
Research output
:
Contribution to conference
›
Poster
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Analysing the impact of gabapentinoid reclassification on prescribing rates in the UK'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Defined Daily Dose
72%
Drug Misuse
9%
Gabapentin
63%
Gabapentinoids
100%
Intentional Overdose
9%
Interrupted Time Series
18%
Linear Regression Modeling
9%
Monthly Number
9%
Negative Trend
9%
Northern Ireland
63%
Positive Trend
9%
Pregabalin
63%
Prescribing Rates
100%
Prescribing Trends
18%
Prescription Pattern
27%
Reclassification
100%
Relative Change
36%
Road Traffic Accidents
9%
Robustness Analysis
9%
Scotland
45%
Scottish
9%
Somatosensory System
9%
Suicidal Behavior
9%
Trend Following
9%
Wales
54%
World Health Organization
9%
Year 2018
9%
Pharmacology, Toxicology and Pharmaceutical Science
Defined Daily Dose
88%
Diseases
11%
Drug Misuse
11%
Gabapentin
77%
Gabapentinoid
100%
Pregabalin
77%
Toxic Injury
11%
Agricultural and Biological Sciences
Somatosensory System
50%
Time Series Analysis
100%
World Health Organization
50%